• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pretransplant increasing rate of lactate dehydrogenase as a predictor of transplant outcomes for patients with myeloid hematological malignancies.

作者信息

Morishita Takanobu, Matsumoto Rena, Naito Tomoki, Domon Yosuke, Takeda Kenichiro, Ishigiwa Kohei, Ichiki Tomoe, Okabe Motohito, Eguchi Motoki, Kawaguchi Yuka, Ohbiki Marie, Goto Tatsunori, Ozawa Yukiyasu, Miyamura Koichi

机构信息

Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

出版信息

Bone Marrow Transplant. 2021 Jul;56(7):1732-1736. doi: 10.1038/s41409-021-01241-w. Epub 2021 Mar 8.

DOI:10.1038/s41409-021-01241-w
PMID:33686247
Abstract
摘要

相似文献

1
Pretransplant increasing rate of lactate dehydrogenase as a predictor of transplant outcomes for patients with myeloid hematological malignancies.移植前乳酸脱氢酶升高率作为髓系血液系统恶性肿瘤患者移植结局的预测指标
Bone Marrow Transplant. 2021 Jul;56(7):1732-1736. doi: 10.1038/s41409-021-01241-w. Epub 2021 Mar 8.
2
Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry.1993年在欧洲进行的5651例血液系统恶性肿瘤造血干细胞移植的结果：登记处的可靠性研究
Bone Marrow Transplant. 2002 Nov;30(10):637-43. doi: 10.1038/sj.bmt.1703712.
3
Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid Malignancies.移植前维生素 D 缺乏与接受异体骨髓恶性肿瘤移植患者的更高复发率相关。
J Clin Oncol. 2017 Sep 20;35(27):3143-3152. doi: 10.1200/JCO.2017.73.0085. Epub 2017 Aug 3.
4
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.对晚期血液系统恶性肿瘤患者进行非清髓性预处理的异基因造血细胞移植。
Cytotherapy. 2001;3(4):253-60. doi: 10.1080/146532401317070880.
5
Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review.非清髓性异基因干细胞移植治疗血液系统恶性肿瘤：一项系统评价
Cancer Control. 2003 Jan-Feb;10(1):17-41. doi: 10.1177/107327480301000104.
6
Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation.异体干细胞移植中全肺功能测试衍生的预后预测因子。
Biol Blood Marrow Transplant. 2019 Jan;25(1):129-136. doi: 10.1016/j.bbmt.2018.07.036. Epub 2018 Jul 29.
7
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.对于先前造血干细胞移植后复发的晚期血液系统恶性肿瘤患者，采用氟达拉滨和美法仑进行预处理。
Bone Marrow Transplant. 2001 Sep;28(6):557-62. doi: 10.1038/sj.bmt.1703198.
8
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.在单倍体移植中，低剂量全身照射联合氟达拉滨和美法仑预处理用于高危血液系统恶性肿瘤的治疗
Transplantation. 2017 Jan;101(1):e34-e38. doi: 10.1097/TP.0000000000001538.
9
Dental management of pediatric patients undergoing hematopoietic stem cell transplant.接受造血干细胞移植的儿科患者的牙科管理
Pediatr Hematol Oncol. 2006 Oct-Nov;23(7):541-8. doi: 10.1080/08880010600814187.
10
Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic Malignancies.验证血液恶性肿瘤患者移植后生存预测的造血细胞移植综合风险（HCT-CR）模型。
Clin Cancer Res. 2020 May 15;26(10):2404-2410. doi: 10.1158/1078-0432.CCR-19-3919. Epub 2020 Feb 4.

引用本文的文献

1
The relationship between objective measures of physical function and serum lactate dehydrogenase in older adults with cancer prior to treatment.治疗前癌症老年患者的身体功能客观测量指标与血清乳酸脱氢酶的关系。
PLoS One. 2022 Oct 6;17(10):e0275782. doi: 10.1371/journal.pone.0275782. eCollection 2022.